DD

Dipannita Dan

Active Director Director DIN 08963855
DIN 08963855 First appointment Nov 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2020
Shareholding value Locked Premium profile

About Dipannita Dan

Dipannita Dan has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Enphamed Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 08963855
Primary Designation Director
First Appointment 18 Nov 2020
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Enphamed Biotech Private Limited U24239WB2020PTC241333
Director 18 Nov 2020 2020 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Enphamed Biotech Private Limited
Premium access

Shareholding and investment profile for Dipannita Dan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipannita Dan

Dipannita Dan has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Enphamed Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Dipannita Dan is associated with 1 company as Director.

Dipannita Dan has expertise in Technology.

Dipannita Dan has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available